A Gene Editing First Augurs an Era of Bespoke Therapies
P.J. Brooks, deputy director of the Office of Rare Disease Research at the National Institutes of Health’s National Center for Advancing Translational Sciences, discusses the recent treatment of an infant with a bespoke gene editing therapy, how the researchers were able to move from diagnosis to treatment with great speed, and what it would take to scale such an approach.